Suppressa P - Search Results

1

European Reference Network for Rare Vascular Diseases (VASCERN): When and how to use intravenous bevacizumab in Hereditary Haemorrhagic Telangiectasia (HHT)?

Dupuis-Girod S, Shovlin CL, Kjeldsen AD, Mager HJ, Sabba C, Droege F, Fargeton AE, Fialla AD, Gandolfi S, Hermann R, Lenato GM, Manfredi G, Post MC, Rennie C, Suppressa P, Sure U; ePag group; Buscarini E. Dupuis-Girod S, et al. Among authors: suppressa p. Eur J Med Genet. 2022 Oct;65(10):104575. doi: 10.1016/j.ejmg.2022.104575. Epub 2022 Aug 5. Eur J Med Genet. 2022. PMID: 35940549 Free article.

2

Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study.

Bertolotti M, Franchi C, Rocchi MB, Miceli A, Libbra MV, Nobili A, Lancellotti G, Carulli L, Mussi C; REPOSI Investigators. Bertolotti M, et al. Drugs Aging. 2017 Apr;34(4):311-319. doi: 10.1007/s40266-017-0448-8. Drugs Aging. 2017. PMID: 28299634

3

Prescription appropriateness of anti-diabetes drugs in elderly patients hospitalized in a clinical setting: evidence from the REPOSI Register.

Succurro E, Novella A, Nobili A, Giofrè F, Arturi F, Sciacqua A, Andreozzi F, Pietrangelo A, Sesti G; REPOSI Investigators. Succurro E, et al. Intern Emerg Med. 2023 Jun;18(4):1049-1063. doi: 10.1007/s11739-023-03254-3. Epub 2023 Mar 25. Intern Emerg Med. 2023. PMID: 36964858 Free PMC article.

4

Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register.

Mannucci PM, Nobili A, Pasina L; REPOSI Collaborators (REPOSI is the acronym of REgistro POliterapie SIMI, Società Italiana di Medicina Interna). Mannucci PM, et al. Intern Emerg Med. 2018 Dec;13(8):1191-1200. doi: 10.1007/s11739-018-1941-8. Epub 2018 Aug 31. Intern Emerg Med. 2018. PMID: 30171585 Review.

5

Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register.

Rossio R, Ardoino I, Franchi C, Nobili A, Mannuccio Mannucci P, Peyvandi F; REPOSI Investigators. Rossio R, et al. Intern Emerg Med. 2019 Nov;14(8):1347-1352. doi: 10.1007/s11739-019-02178-1. Epub 2019 Aug 23. Intern Emerg Med. 2019. PMID: 31444740 Free article. No abstract available.

6

How to assess and manage cardiovascular risk associated with lipid alterations beyond LDL.

Averna M, Stroes E; lipid alterations beyond LDL expert working group. Averna M, et al. Atheroscler Suppl. 2017 Apr;26:16-24. doi: 10.1016/S1567-5688(17)30021-1. Atheroscler Suppl. 2017. PMID: 28434480 Review.

7

Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study.

Raparelli V, Pastori D, Pignataro SF, Vestri AR, Pignatelli P, Cangemi R, Proietti M, Davì G, Hiatt WR, Lip GYH, Corazza GR, Perticone F, Violi F, Basili S; ARAPACIS Study Collaborators. Raparelli V, et al. Intern Emerg Med. 2018 Dec;13(8):1349. doi: 10.1007/s11739-018-1922-y. Intern Emerg Med. 2018. PMID: 30076553

8

Correction to: Prescription appropriateness of anti-diabetes drugs in elderly patients hospitalized in a clinical setting: evidence from the REPOSI Register.

Succurro E, Novella A, Nobili A, Giofrè F, Arturi F, Sciacqua A, Andreozzi F, Pietrangelo A, Sesti G; REPOSI Investigators. Succurro E, et al. Intern Emerg Med. 2023 Aug;18(5):1611. doi: 10.1007/s11739-023-03361-1. Intern Emerg Med. 2023. PMID: 37535294 Free PMC article. No abstract available.

9

Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study.

Basili S, Raparelli V, Napoleone L, Talerico G, Corazza GR, Perticone F, Sacerdoti D, Andriulli A, Licata A, Pietrangelo A, Picardi A, Raimondo G, Violi F; PRO-LIVER Collaborators. Basili S, et al. Am J Gastroenterol. 2018 Mar;113(3):368-375. doi: 10.1038/ajg.2017.457. Epub 2017 Dec 19. Am J Gastroenterol. 2018. PMID: 29257146

10

Lipoprotein(a) and family history for cardiovascular disease in paediatric patients: A new frontier in cardiovascular risk stratification. Data from the LIPIGEN paediatric group.

Pederiva C, Capra ME, Biasucci G, Banderali G, Fabrizi E, Gazzotti M, Casula M, Catapano AL; LIPIGEN Paediatric Group; MEMBERS OF THE LIPIGEN STEERING COMMITTEE; Arca M, Averna M, Bertolini S, Calandra S, Catapano AL, Tarugi P; PRINCIPAL INVESTIGATORS; Coordinator center; Pellegatta F; Participant Centers; Participant COLLABORATORS; STUDY COORDINATING GROUP. Pederiva C, et al. Atherosclerosis. 2022 May;349:233-239. doi: 10.1016/j.atherosclerosis.2022.04.021. Epub 2022 Apr 25. Atherosclerosis. 2022. PMID: 35562202

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

110 results

Search Page